Author

Gerhard Jungwirth

German Cancer Research CenterORCID 0000-0001-7571-8947Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:human· 3 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Andreas von DeimlingiD· 3 shared Christel C. Herold‐MendeiD· 3 shared Felix SahmiD· 3 shared Andreas Wilhelm UnterbergiD· 2 shared Catharina LotschiD· 2 shared Katrin LamszusiD· 2 shared Manfred WestphaliD· 2 shared Philipp SieversiD· 2 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Andreas von DeimlingORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyScience Translational MedicinePeer-reviewedMar 4, 2026

Personalized Medicine for Meningiomas: Drug Screening on Tumor Organoids Exposes Therapeutic Vulnerabilities to HDAC1/2i Panobinostat

Gerhard Jungwirth, Junguo Cao, Yimin Pan…·Christel C. Herold‐Mende

This study identifies panobinostat as an effective treatment for aggressive meningiomas through drug screening on tumor organoids and reveals a resistance mechanism involving the HDAC8-TGFβ-EMT axis.

6 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyActa NeuropathologicaPeer-reviewedOct 9, 2025

Tumor-Associated Macrophages in Meningiomas: An Independent Prognostic Factor for Poor Survival Outperforming the Benefits of T cells

Catharina Lotsch, Rolf Warta, Fang Liu…·Christel C. Herold‐Mende

This study identifies high M2-TAM infiltration as an independent poor survival prognostic factor in meningiomas, overriding the beneficial effect of TILs.

10 citations

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsbioRxivPreprintMay 11, 2021

Integrated phospho-proteogenomic and single-cell transcriptomic analysis of meningiomas establishes robust subtyping and reveals subtype-specific immune invasion

Christina Blume, Helin Dogan, Lisa Schweizer…·Felix Sahm

This study integrates phospho-proteogenomic and single-cell transcriptomic data to subtype meningiomas and identify subtype-specific immune infiltration patterns.

8 citations

humanbulk RNA-seq

𝕏 PostBluesky